![Job Komen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Job Komen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Gilde Healthcare Partners BV
![]() Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge.
8
| Subsidiary | Investment Managers | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Job Komen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Parcom Capital Management BV
![]() Parcom Capital Management BV Investment ManagersFinance Parcom Capital Management BV is an independent private equity firm founded in 1982. Parcom Capital Management BV is headquartered in Amsterdam. | Investment Managers | Private Equity Analyst | |
Draupnir Bio ApS
![]() Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Investor | |
ADCendo ApS
![]() ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Anterra Capital BV
![]() Anterra Capital BV Investment ManagersFinance Anterra Capital BV (Anterra Capital) is an independent private equity firm founded in 2013. The firm is headquartered in Amsterdam, Netherlands. | Investment Managers | Private Equity Analyst | |
Veris Investments BV
![]() Veris Investments BV Investment ManagersFinance Veris Investments BV is an independent investment company founded in 2013 having headquartered at Amsterdam, The Netherlands. | Investment Managers | Private Equity Investor | |
Rabo Private Equity
![]() Rabo Private Equity Investment ManagersFinance Rabo Private Equity (RPE) is the private equity arm of the Rabobank Group and is headquartered in Utrecht. RPE originated in 1972 following the merger of two separate Dutch cooperative banks, the Cooperatieve Centrale Raiffeisen-Boerenleenbank in Utrecht and the Cooperatieve Centrale Boerenleenbank in Eindhoven. The firm was formally established in 1998. RPE is based in Utrecht and operates through two separate entities, Rabo Participaties and Rabo Capital. | Investment Managers | Private Equity Investor | |
Amphista Therapeutics Ltd.
![]() Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Biotechnology | Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree | |
Ice Lake Capital Management BV
![]() Ice Lake Capital Management BV Investment ManagersFinance Ice Lake Capital Management BV (IceLake Capital) is a private equity firm founded in 2018 by Bastiaan Hagenouw, Matteo Racca and Vincent Lüning. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Founder | |
Swiss Federal Institute of Technology | College/University | Graduate Degree | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
INSEAD | College/University | Masters Business Admin | |
Erasmus University Rotterdam | College/University | Graduate Degree | |
University of Bocconi | College/University | Undergraduate Degree | |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Pharmaceuticals: Other | Director/Board Member | |
Synexa Life Sciences BV
![]() Synexa Life Sciences BV BiotechnologyHealth Technology Synexa Life Sciences BV is a Dutch company that specializes in Biomarker and Bioanalysis Research Services. The company is based in Leiden, Netherlands. The company has expertise in designing and delivering biomarker strategies for biopharma clients. and has subsidiaries in Finland. The company was founded in 2003 by Justin Devine, Patrick Bouic, Paul O'Riordan. The CEO is Emile Lens. | Biotechnology | Director/Board Member |
Statistik
International
Niederlande | 10 |
Vereinigtes Königreich | 4 |
Dänemark | 3 |
Schweiz | 2 |
Frankreich | 2 |
Sektoral
Finance | 7 |
Health Technology | 7 |
Consumer Services | 6 |
Operativ
Private Equity Investor | 10 |
Private Equity Analyst | 8 |
Director/Board Member | 6 |
Graduate Degree | 3 |
Undergraduate Degree | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Matteo Racca | 7 |
Stefan Luzi | 6 |
Sanne de Jongh | 4 |
Daan Meijners | 3 |
Redmar Koene | 2 |
Joep Heldens | 1 |
Henry Zubaida | 1 |
Rafael Natanek | 1 |